Cargando…

Reversal of Apixaban Induced Alterations in Hemostasis by Different Coagulation Factor Concentrates: Significance of Studies In Vitro with Circulating Human Blood

Apixaban is a new oral anticoagulant with a specific inhibitory action on FXa. No information is available on the reversal of the antihemostatic action of apixaban in experimental or clinical settings. We have evaluated the effectiveness of different factor concentrates at reversing modifications of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Escolar, Gines, Fernandez-Gallego, Victor, Arellano-Rodrigo, Eduardo, Roquer, Jaume, Reverter, Joan Carles, Sanz, Victoria Veronica, Molina, Patricia, Lopez-Vilchez, Irene, Diaz-Ricart, Maribel, Galan, Ana Maria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3823858/ https://www.ncbi.nlm.nih.gov/pubmed/24244342 http://dx.doi.org/10.1371/journal.pone.0078696

Ejemplares similares

Differential inhibitory action of apixaban on platelet and fibrin components of forming thrombi: Studies with circulating blood and in a platelet-based model of thrombin generation
por: Pujadas-Mestres, Lluis, et al.
Publicado: (2017)

Hemostasis-On-a-Chip: Impedance Spectroscopy Meets Microfluidics for Hemostasis Evaluation
por: Karimi, Shadi, et al.
Publicado: (2019)

Impact of different pathogen reduction technologies on the biochemistry, function, and clinical effectiveness of platelet concentrates: An updated view during a pandemic
por: Escolar, Gines, et al.
Publicado: (2021)

NFκB in the Development of Endothelial Activation and Damage in Uremia: An In Vitro Approach
por: Caballo, Carolina, et al.
Publicado: (2012)

Effects of Hyperglycemia and Diabetes Mellitus on Coagulation and Hemostasis
por: Li, Xiaoling, et al.
Publicado: (2021)

Effect of apixaban compared with warfarin on coagulation markers in atrial fibrillation
por: Christersson, Christina, et al.
Publicado: (2019)

Mechanistic Basis for the Differential Effects of Rivaroxaban and Apixaban on Global Tests of Coagulation
por: Kim, Paul Y., et al.
Publicado: (2018)

Mechanism Action of Platelets and Crucial Blood Coagulation Pathways in Hemostasis
por: Periayah, Mercy Halleluyah, et al.
Publicado: (2017)

Endothelial damage in major depression patients is modulated by SSRI treatment, as demonstrated by circulating biomarkers and an in vitro cell model
por: Lopez-Vilchez, I, et al.
Publicado: (2016)

Pathologies at the nexus of blood coagulation and inflammation: thrombin in hemostasis, cancer, and beyond
por: Danckwardt, Sven, et al.
Publicado: (2013)

Hemostasis during the early stages of trauma: comparison with disseminated intravascular coagulation
por: Oshiro, Akiko, et al.
Publicado: (2014)

Enzymatic lipid oxidation by eosinophils propagates coagulation, hemostasis, and thrombotic disease
por: Uderhardt, Stefan, et al.
Publicado: (2017)

Guidance on the critical shortage of sodium citrate coagulation tubes for hemostasis testing
por: Gosselin, Robert C., et al.
Publicado: (2021)

Reference Intervals for Coagulation Parameters in Developmental Hemostasis from Infancy to Adolescence
por: Di Felice, Giovina, et al.
Publicado: (2022)

Endothelial Progenitor Cells Predict Cardiovascular Events after Atherothrombotic Stroke and Acute Myocardial Infarction. A PROCELL Substudy
por: Cuadrado-Godia, Elisa, et al.
Publicado: (2015)

Local hemostasis, immunothrombosis, and systemic disseminated intravascular coagulation in trauma and traumatic shock
por: Gando, Satoshi, et al.
Publicado: (2015)

Correction: Enzymatic lipid oxidation by eosinophils propagates coagulation, hemostasis, and thrombotic disease
por: Uderhardt, Stefan, et al.
Publicado: (2018)

The adhesion of clots in wounds contributes to hemostasis and can be enhanced by coagulation factor XIII
por: Chan, Karen Y. T., et al.
Publicado: (2020)

Hemoperfusion leads to impairment in hemostasis and coagulation process in patients with acute pesticide intoxication
por: Park, Samel, et al.
Publicado: (2019)

Hemostasis, coagulation and thrombin in venoarterial and venovenous extracorporeal membrane oxygenation: the HECTIC study
por: Cartwright, Bruce, et al.
Publicado: (2021)

Assessment of Coagulation and Hemostasis Biomarkers in a Subset of Patients With Chronic Cardiovascular Disease
por: Miller, Maureen J., et al.
Publicado: (2021)

Risk Factors for Transurethral Coagulation for Hemostasis During Holmium Laser Enucleation of the Prostate
por: Yoon, Hyun Sik, et al.
Publicado: (2022)

PROTEIN COAGULATION AND ITS REVERSAL : THE REVERSAL OF THE COAGULATION OF HEMOGLOBIN
por: Mirsky, A. E., et al.
Publicado: (1929)

Measurement of coagulation factors during rivaroxaban and apixaban treatment: Results from two crossover trials
por: Scheres, Luuk J. J., et al.
Publicado: (2018)

Evaluation of the effect of apixaban using a viscoelastic coagulation assay with Russell’s viper venom reagent
por: Suzuki, Kaoru, et al.
Publicado: (2021)

Role of sodium tungstate as a potential antiplatelet agent
por: Fernández-Ruiz, Rebeca, et al.
Publicado: (2015)

Routine Hemostasis and Hemogram Parameters: Valuable Assessments for Coagulation Disorder and Chemotherapy in Cancer Patients
por: Zhu, Ying-Wei, et al.
Publicado: (2016)

Biochemical, molecular and clinical aspects of coagulation factor VII and its role in hemostasis and thrombosis
por: Bernardi, Francesco, et al.
Publicado: (2021)

Commentary on “Risk Factors for Transurethral Coagulation for Hemostasis During Holmium Laser Enucleation of the Prostate”
por: Maheshwari, Pankaj N., et al.
Publicado: (2022)

Efficacy of non-specific hemostatic agents for reversal of prophylactic apixaban levels
por: Schmidt, K, et al.
Publicado: (2015)

Ciraparantag reverses the anticoagulant activity of apixaban and rivaroxaban in healthy elderly subjects
por: Ansell, Jack, et al.
Publicado: (2021)

Reversal of apixaban and rivaroxaban with andexanet alfa prior to invasive or surgical procedures
por: Bradshaw, Paige Garber, et al.
Publicado: (2022)

PROTEIN COAGULATION AND ITS REVERSAL : IMPROVED METHODS FOR THE REVERSAL OF THE COAGULATION OF HEMOGLOBIN
por: Mirsky, A. E., et al.
Publicado: (1930)

Liposomes bearing fibrinogen could potentially interfere with platelet interaction and procoagulant activity
por: Hernández, M Rosa, et al.
Publicado: (2012)

Preparation of Apixaban Solid Dispersion for the Enhancement of Apixaban Solubility and Permeability
por: Lee, Juseung, et al.
Publicado: (2023)

Laser coagulation and hemostasis of large diameter blood vessels: effect of shear stress and flow velocity
por: Katta, Nitesh, et al.
Publicado: (2022)

Reply to Commentary on “Risk Factors for Transurethral Coagulation for Hemostasis During Holmium Laser Enucleation of the Prostate”
por: Yoon, Hyun Sik, et al.
Publicado: (2022)

Monitoring the Coagulation Profile of COVID-19 Patients Using Standard and ClotPro(®) Hemostasis Tests
por: Milić, Dragan, et al.
Publicado: (2023)

Endothelial Damage, Inflammation and Immunity in Chronic Kidney Disease
por: Diaz-Ricart, Maribel, et al.
Publicado: (2020)

Análisis coste-utilidad de apixabán frente al ácido acetilsalicílico en la prevención del ictus en pacientes con fibrilación auricular no valvular en España
por: Escolar-Albaladejo, Ginés, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_75rqrmu76gg0pgaggh4heugsl8